![Sanofi Launches 'Once Daily' Oral, Teriflunomide 14 mg Tablet 'Aubagio®'- for Treatment of Multiple Sclerosis in India Sanofi Launches 'Once Daily' Oral, Teriflunomide 14 mg Tablet 'Aubagio®'- for Treatment of Multiple Sclerosis in India](https://mma.prnewswire.com/media/793371/Aubagio_Teriflunomide_14_mg.jpg?p=twitter)
Sanofi Launches 'Once Daily' Oral, Teriflunomide 14 mg Tablet 'Aubagio®'- for Treatment of Multiple Sclerosis in India
![FDA approves Genzyme's AUBAGIO® (teriflunomide) - Society for Multiple Sclerosis Patients in Pakistan FDA approves Genzyme's AUBAGIO® (teriflunomide) - Society for Multiple Sclerosis Patients in Pakistan](https://blog.smspp.org.pk/wp-content/themes/florentia/images/posts/Aubagio-tablets.jpg)
FDA approves Genzyme's AUBAGIO® (teriflunomide) - Society for Multiple Sclerosis Patients in Pakistan
![AUBAGIO Price | Buy Generic teriflunomide | Multiple Sclerosis Treatment | Available in India UK UAE Turkey Egypt AUBAGIO Price | Buy Generic teriflunomide | Multiple Sclerosis Treatment | Available in India UK UAE Turkey Egypt](https://specialitypharma.com/assets/img/medicines/aubagio-teriflunomide.jpg)
AUBAGIO Price | Buy Generic teriflunomide | Multiple Sclerosis Treatment | Available in India UK UAE Turkey Egypt
![JAMP Pharma Group Launches PrJAMP Teriflunomide, a New Generic for the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis - JAMP Pharma JAMP Pharma Group Launches PrJAMP Teriflunomide, a New Generic for the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis - JAMP Pharma](https://www.jamppharma.ca/wp-content/uploads/2022/05/JAMP-Teriflunomide.png)